2549. Pharmacometric Analyses to Support Sulbactam-Durlobactam (SUL-DUR) Dosing Regimens in Patients with Altered Renal Function

por Larson, Kajal, Bhavnani, Sujata M, Hammel, Jeffrey P, Cammarata, Anthony P, O’Donnell, John, Rubino, Christopher M
Publicado 2023

Comparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn’s disease

por Navaneethan, Udayakumar, Venkatesh, Preethi GK, Jegadeesan, Ramprasad, Lourdusamy, Vennisvasanth, Hammel, Jeffrey P, Kiran, Ravi P, Shen, Bo
Publicado 2016

Dataset on growth factor levels and insulin use in patients with diabetes mellitus and incident breast cancer

por Wintrob, Zachary A.P., Hammel, Jeffrey P., Nimako, George K., Gaile, Dan P., Forrest, Alan, Ceacareanu, Alice C.
Publicado 2017

Dataset on granulopoiesis- and lymphopoiesis-stimulating cytokine levels in insulin secretagogue users with incident breast cancer

por Wintrob, Zachary A.P., Hammel, Jeffrey P., Nimako, George K., Gaile, Dan P., Forrest, Alan, Ceacareanu, Alice C.
Publicado 2017

TH1 and TH2 cytokines dataset in insulin users with diabetes mellitus and newly diagnosed breast cancer

por Wintrob, Zachary A.P., Hammel, Jeffrey P., Nimako, George K., Gaile, Dan P., Forrest, Alan, Ceacareanu, Alice C.
Publicado 2017

Insulin use, hormone receptor status and hematopoietic cytokines׳ circulation in women with diabetes mellitus and breast cancer

por Wintrob, Zachary A.P., Hammel, Jeffrey P., Nimako, George K., Gaile, Dan P., Forrest, Alan, Ceacareanu, Alice C.
Publicado 2017

TH1 and TH2 cytokine data in insulin secretagogues users newly diagnosed with breast cancer

por Wintrob, Zachary A.P., Hammel, Jeffrey P., Nimako, George K., Gaile, Dan P., Forrest, Alan, Ceacareanu, Alice C.
Publicado 2017

Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer

por Wintrob, Zachary A.P., Hammel, Jeffrey P., Nimako, George K., Gaile, Dan P., Forrest, Alan, Ceacareanu, Alice C.
Publicado 2017

Circulating adipokines data associated with insulin secretagogue use in breast cancer patients

por Wintrob, Zachary A.P., Hammel, Jeffrey P., Nimako, George K., Fayazi, Zahra S., Gaile, Dan P., Forrest, Alan, Ceacareanu, Alice C.
Publicado 2016

Insulin secretagogue use and circulating inflammatory C–C chemokine levels in breast cancer patients

por Wintrob, Zachary A.P., Hammel, Jeffrey P., Nimako, George K., Fayazi, Zahra S., Gaile, Dan P., Forrest, Alan, Ceacareanu, Alice C.
Publicado 2017

Is hyponatremia associated with mortality in pulmonary arterial hypertension?

por Rudkovskaia, Anastasiia A., Tonelli, Adriano R., Rao, Youlan, Hammel, Jeffrey P., Buller, Gregory K., Dweik, Raed A., Fares, Wassim H.
Publicado 2018

Data report on inflammatory C–C chemokines among insulin-using women with diabetes mellitus and breast cancer

por Wintrob, Zachary A.P., Hammel, Jeffrey P., Nimako, George K., Fayazi, Zahra S., Gaile, Dan P., Davis, Erin E., Forrest, Alan, Ceacareanu, Alice C.
Publicado 2017

2562. Re-Appraisal of Aminoglycoside (AG) Susceptibility Testing Breakpoints Based on the Application of Pharmacokinetics–Pharmacodynamics (PK-PD) and Contemporary Microbiology Sur...

por Bhavnani, Sujata M, Onufrak, Nikolas J, Hammel, Jeffrey P, Andes, David R, Bradley, John S, Flamm, Robert K, Ambrose, Paul G, Jones, Ronald N
Publicado 2018

Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial...

por Bhavnani, Sujata M, Zhang, Li, Hammel, Jeffrey P, Rubino, Christopher M, Bader, Justin C, Sader, Helio S, Gelone, Steven P, Wicha, Wolfgang W, Ambrose, Paul G
Publicado 2019

2530. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Ceftobiprole Dose Selection for the Treatment of Patients with Acute Bacterial Skin and Skin Str...

por Bhavnani, Sujata M, Hammel, Jeffrey P, Rinaldo, Anthony J, Smart, Jennifer, Litherland, Karine, Duncan, Leonard R, Jones, Mark E, Engelhardt, Marc, Ambrose, Paul G, Rubino, Christopher M
Publicado 2023

2531. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Ceftobiprole Dosing Regimens for Patients with Staphylococcus aureus Bacteremia (SAB)

por Bhavnani, Sujata M, Hammel, Jeffrey P, Rinaldo, Anthony J, Smart, Jennifer, Litherland, Karine, Duncan, Leonard R, Jones, Mark E, Engelhardt, Marc, Ambrose, Paul G, Rubino, Christopher M
Publicado 2023

1392. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Inhaled ME1100 Dose Selection

por Bhavnani, Sujata M, Hammel, Jeffrey P, Lakota, Elizabeth A, VanScoy, Brian D, Nagira, Yu, Rubino, Christopher M, Sato, Nobuo, Koresawa, Tomokazu, Kondo, Kenichiro, Ambrose, Paul G
Publicado 2018

2532. Pharmacokinetic-Pharmacodynamic Analyses for Ceftobiprole Efficacy Based on Phase 3 Data from Patients with Staphylococcus aureus Bacteremia

por Bhavnani, Sujata M, Hammel, Jeffrey P, Liolios, Kathryn, Cammarata, Anthony P, Saulay, Mikael, Rubino, Christopher M, Engelhardt, Marc, Smart, Jennifer, Jones, Mark E, Ambrose, Paul G, Litherland, Karine
Publicado 2023

The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease

por Comhair, Suzy A. A., Bochenek, Grazyna, Baicker-McKee, Sara, Wang, Zeneng, Stachura, Tomasz, Sanak, Marek, Hammel, Jeffrey P., Hazen, Stanley L., Erzurum, Serpil C., Nizankowska-Mogilnicka, Ewa
Publicado 2018

733. Pharmacokinetic–Pharmacodynamic (PK–PD) Analyses for Alanine Aminotransferase (ALT) Using Phase 3 Data From Omadacycline (OMC)-Treated Patients

por Bhavnani, Sujata M, Trang, Michael, George, Darryl R, Liolios, Kathryn, McGovern, Paul C, Friedrich, Lawrence, Steenbergen, Judith N, Rubino, Christopher M, Tzanis, Evan, Ambrose, Paul G, Hammel, Jeffrey P
Publicado 2019